Cas:54247-51-7 3-Aminopyridine-2-sulfonic acid manufacturer & supplier

We serve Chemical Name:3-Aminopyridine-2-sulfonic acid CAS:54247-51-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-Aminopyridine-2-sulfonic acid

Chemical Name:3-Aminopyridine-2-sulfonic acid
CAS.NO:54247-51-7
Synonyms:3-Amino-2-pyridine sulfonic acid;3-Amino-pyridin-2-sulfonsaeure;3-azanylpyridine-2-sulfonic acid;2-Pyridinesulfonicacid,3-amino;3-amino-pyridine-2-sulfonic acid
Molecular Formula:C5H6N2O3S
Molecular Weight:174.17800
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.617g/cm3
Index of Refraction:1.634
PSA:101.66000
Exact Mass:174.01000
LogP:1.57250

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-Amino-2-pyridine sulfonic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-amino-pyridine-2-sulfonic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-azanylpyridine-2-sulfonic acid Use and application,3-amino-pyridine-2-sulfonic acid technical grade,usp/ep/jp grade.


Related News: As a result, the team identified and prioritized studies that would provide the necessary product and process understanding needed to develop a control strategy, ensure the reproducibility of the product, and meet its intended safety, efficacy, stability, and performance profile regardless of the manufacturing scale. 2,3-Dihydrobenzofuran-5-ethanol Tosylate manufacturers The jury unanimously ruled in Plexxikon’s favor on all seven questions, including that Novartis has not proved the specification of the patent was full and clear enough to enable a person of “ordinary skill” to make and use the invention. Hydralazine hydrochloride suppliers The three products for which it received the PLI approvals are betamethasone with a production capacity of 12 MT at an investment of Rs 31.43 crore, dexamethasone of 10 MT with an investment of Rs. 26.19 crore and prednisolone of 15 MT at Rs 39. 29 crore. This takes the total investment to Rs 96.91 core. Furcellaran vendor & factory.